HYAL3 and bladder transitional cell carcinoma: The results showed that BLCA cases with lower HYAL3 mRNA expression levels had a significantly longer OS in the TCGA-BLCA cohort (P < 0.001; Fig. 5a), and similar findings were also observed in the GSE31684 cohort (P = 0.004; Fig. 5b).